These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3726533)

  • 61. Platelet-derived growth factor-modulated proteins: constitutive synthesis by a transformed cell line.
    Pledger WJ; Hart CA; Locatell KL; Scher CD
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4358-62. PubMed ID: 6170062
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Inhibition of MCF-7ras tumor growth by carboxymethyl benzylamide dextran: blockage of the paracrine effect and receptor binding of transforming growth factor beta1 and platelet-derived growth factor-BB.
    Bagheri-Yarmand R; Kourbali Y; Morère JF; Jozefonvicz J; Crépin M
    Cell Growth Differ; 1998 Jun; 9(6):497-504. PubMed ID: 9663468
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Protein tyrosine phosphorylation in the cell cycle of BALB/c 3T3 fibroblasts.
    Morla AO; Wang JY
    Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8191-5. PubMed ID: 3464948
    [TBL] [Abstract][Full Text] [Related]  

  • 64. CDGF (chicken embryo fibroblast-derived growth factor) is mitogenically related to TGF-beta and modulates PDGF, bFGF, and IGF-I action on sparse NIH/3T3 cells.
    Geistlich A; Gehring H
    Exp Cell Res; 1993 Feb; 204(2):329-35. PubMed ID: 8440329
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines.
    Bronzert DA; Pantazis P; Antoniades HN; Kasid A; Davidson N; Dickson RB; Lippman ME
    Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5763-7. PubMed ID: 3039506
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Retinyl acetate inhibits platelet-derived growth factor-induced Ca2+ signals in C3H 10T1/2 fibroblasts.
    Hill TD; Boynton AL; Dean NM; Mordan LJ
    J Cell Physiol; 1990 Aug; 144(2):229-36. PubMed ID: 2380253
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Biological properties of a hepatocyte growth factor from rat platelets.
    Russell WE; McGowan JA; Bucher NL
    J Cell Physiol; 1984 May; 119(2):193-7. PubMed ID: 6715417
    [TBL] [Abstract][Full Text] [Related]  

  • 68. G1 phase heterogeneity in exponentially growing Swiss 3T3 mouse fibroblasts.
    Sturani E; Toschi L; Zippel R; Martegani E; Alberghina L
    Exp Cell Res; 1984 Jul; 153(1):135-44. PubMed ID: 6734735
    [TBL] [Abstract][Full Text] [Related]  

  • 69. An interferon-induced 16-kD protein is present in the membranes of interferon-sensitive but not in interferon-resistant mouse cells.
    Vignaux F; Knight E; Eid P; Gresser I
    J Interferon Res; 1991 Jun; 11(3):123-30. PubMed ID: 1919072
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Growth-state independent induction of specific proteins in Swiss 3T3 cells by interferon.
    Sundström S; Ny T; Lundgren E
    J Interferon Res; 1983; 3(2):223-9. PubMed ID: 6192187
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Serum-induced G0/G1 transition in chemically transformed 3T3 cells. Independence of protein synthesis, stable "memory", and enhancement by cycloheximide pretreatment.
    Gray HE; Buchou T; Mester J
    Exp Cell Res; 1987 Mar; 169(1):95-104. PubMed ID: 3545864
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A 63 kDa protein is secreted from BALB/c-3T3 cells entering the G1 phase from the G0 state.
    Tominaga S
    FEBS Lett; 1987 Dec; 226(1):53-7. PubMed ID: 3691816
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Update on the treatment of polycythemia vera with recombinant interferon alfa or imatinib mesylate.
    Silver RT
    Curr Hematol Malig Rep; 2007 Feb; 2(1):43-6. PubMed ID: 20425387
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Treatment of polycythemia vera with recombinant interferon.
    Silver RT
    Int J Hematol; 2002 Aug; 76 Suppl 2():294-5. PubMed ID: 12430940
    [No Abstract]   [Full Text] [Related]  

  • 75. Collaboration of signal transducer and activator of transcription 1 (STAT1) and BRCA1 in differential regulation of IFN-gamma target genes.
    Ouchi T; Lee SW; Ouchi M; Aaronson SA; Horvath CM
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5208-13. PubMed ID: 10792030
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Regulation of c-myc expression by IFN-gamma through Stat1-dependent and -independent pathways.
    Ramana CV; Grammatikakis N; Chernov M; Nguyen H; Goh KC; Williams BR; Stark GR
    EMBO J; 2000 Jan; 19(2):263-72. PubMed ID: 10637230
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Stat3 activation is required for cellular transformation by v-src.
    Bromberg JF; Horvath CM; Besser D; Lathem WW; Darnell JE
    Mol Cell Biol; 1998 May; 18(5):2553-8. PubMed ID: 9566875
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Interferon-beta inhibits proliferation and progression through S phase of the cell cycle in five glioma cell lines.
    Garrison JI; Berens ME; Shapiro JR; Treasurywala S; Floyd-Smith G
    J Neurooncol; 1996 Dec; 30(3):213-23. PubMed ID: 8943096
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma.
    Bromberg JF; Horvath CM; Wen Z; Schreiber RD; Darnell JE
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7673-8. PubMed ID: 8755534
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cisplatin, 5-fluorouracil and interferon alpha 2b for recurrent or metastatic head and neck cancer.
    Cascinu S; Fedeli A; Luzi Fedeli S; Catalano G
    Br J Cancer; 1994 Feb; 69(2):392-3. PubMed ID: 8297740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.